PHARMACEUTICAL RESEARCH IN MOLECULAR ONCOLOGY

[11] Freidinger R M, 1993, Prog Drug Res, V40, P33

[12] A SPECIFIC INHIBITOR OF THE EPIDERMAL GROWTH-FACTOR RECEPTOR TYROSINE KINASE [J]. SCIENCE, 1994, 265 (5175) : 1093 - 1095

[13] FRY DW, 1994, EXPERT OPIN INV DRUG, V3, P577

[14] Gibbs J B, 1992, Semin Cancer Biol, V3, P383

[15] FARNESYLTRANSFERASE INHIBITORS - RAS RESEARCH YIELDS A POTENTIAL CANCER THERAPEUTIC [J]. CELL, 1994, 77 (02) : 175 - 178

[16] Gilman AG., 1990, J MED CHEM, V8th, DOI DOI 10.1021/acs.jmedchem.8b01308

[17] GOULD RJ, 1994, DRUG DISCOVERY DESIG, V1, P537

[18] CONFORMATIONAL SHIFTS PROPAGATE FROM THE OLIGOMERIZATION DOMAIN OF P53 TO ITS TETRAMERIC DNA-BINDING DOMAIN AND RESTORE DNA-BINDING TO SELECT P53 MUTANTS [J]. EMBO JOURNAL, 1993, 12 (13) : 5057 - 5064

[19] Harris William, 1993, Drugs of the Future, V18, P727

[20] HUBER HE, 1994, CURR MED CHEM, V1, P13

[11] Freidinger R M, 1993, Prog Drug Res, V40, P33

[12] A SPECIFIC INHIBITOR OF THE EPIDERMAL GROWTH-FACTOR RECEPTOR TYROSINE KINASE [J]. SCIENCE, 1994, 265 (5175) : 1093 - 1095

[13] FRY DW, 1994, EXPERT OPIN INV DRUG, V3, P577

[14] Gibbs J B, 1992, Semin Cancer Biol, V3, P383

[15] FARNESYLTRANSFERASE INHIBITORS - RAS RESEARCH YIELDS A POTENTIAL CANCER THERAPEUTIC [J]. CELL, 1994, 77 (02) : 175 - 178

[16] Gilman AG., 1990, J MED CHEM, V8th, DOI DOI 10.1021/acs.jmedchem.8b01308

[17] GOULD RJ, 1994, DRUG DISCOVERY DESIG, V1, P537

[18] CONFORMATIONAL SHIFTS PROPAGATE FROM THE OLIGOMERIZATION DOMAIN OF P53 TO ITS TETRAMERIC DNA-BINDING DOMAIN AND RESTORE DNA-BINDING TO SELECT P53 MUTANTS [J]. EMBO JOURNAL, 1993, 12 (13) : 5057 - 5064

[19] Harris William, 1993, Drugs of the Future, V18, P727

[20] HUBER HE, 1994, CURR MED CHEM, V1, P13